Example of Case Reports in Endocrinology format
Recent searches

Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format Example of Case Reports in Endocrinology format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Case Reports in Endocrinology — Template for authors

Publisher: Hindawi
Categories Rank Trend in last 3 yrs
Endocrinology, Diabetes and Metabolism #182 of 219 down down by 28 ranks
journal-quality-icon Journal quality:
Low
calendar-icon Last 4 years overview: 133 Published Papers | 77 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 15/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 5.9
SJR: 1.039
SNIP: 1.036
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 5.0
SJR: 1.229
SNIP: 1.653
open access Open Access

Springer

Quality:  
High
CiteRatio: 6.0
SJR: 1.141
SNIP: 1.158
open access Open Access

Springer

Quality:  
High
CiteRatio: 5.0
SJR: 0.649
SNIP: 1.155

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.6

25% from 2019

CiteRatio for Case Reports in Endocrinology from 2016 - 2020
Year Value
2020 0.6
2019 0.8
2018 1.6
2017 1.2
graph view Graph view
table view Table view

0.26

12% from 2019

SJR for Case Reports in Endocrinology from 2017 - 2020
Year Value
2020 0.26
2019 0.297
2018 0.437
2017 0.209
graph view Graph view
table view Table view

0.506

41% from 2019

SNIP for Case Reports in Endocrinology from 2017 - 2020
Year Value
2020 0.506
2019 0.854
2018 0.362
2017 0.488
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 25% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 12% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 41% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Case Reports in Endocrinology

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Hindawi

Case Reports in Endocrinology

Approved by publishing and review experts on SciSpace, this template is built as per for Case Reports in Endocrinology formatting guidelines as mentioned in Hindawi author instructions. The current version was created on 15 Jun 2020 and has been used by 253 authors to write and format their manuscripts to this journal.

Endocrine system diseases

i
Last updated on
15 Jun 2020
i
ISSN
2090-6501
i
Acceptance Rate
Not provided
i
Frequency
Not provided
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. “Specular andreev reflection in graphene”. Phys. Rev. Lett., vol. 97, no. 6, 067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1155/2020/8891539
Subacute Thyroiditis Associated with COVID-19

Abstract:

Subacute thyroiditis is a self-limiting inflammatory disorder, characterized by neck pain or discomfort, a tender diffuse goiter, and sometimes a transient episode of hyperthyroidism followed by euthyroidism and sometimes hypothyroidism. There is usually a normalization of thyroid function within a few weeks. Subacute thyroid... Subacute thyroiditis is a self-limiting inflammatory disorder, characterized by neck pain or discomfort, a tender diffuse goiter, and sometimes a transient episode of hyperthyroidism followed by euthyroidism and sometimes hypothyroidism. There is usually a normalization of thyroid function within a few weeks. Subacute thyroiditis has a higher incidence in summer and has been linked to a viral or bacterial upper respiratory postinfection inflammatory response. We hereby describe the case of a previously healthy 37-year-old female presenting with subacute thyroiditis associated with a very mild presentation of COVID-19. As most patients with SARS-Cov-2 are asymptomatic, we suggest to rule out SARS-Cov-2 infection in patients presenting with symptoms suggesting SAT. read more read less

Topics:

Subacute thyroiditis (78%)78% related to the paper, Thyroid function (54%)54% related to the paper, Asymptomatic (50%)50% related to the paper
View PDF
56 Citations
open accessOpen access Journal Article DOI: 10.1155/2016/2087525
Treatment of Ipilimumab Induced Graves' Disease in a Patient with Metastatic Melanoma.
Umal Azmat1, David A. Liebner1, Amy Joehlin-Price1, Amit Agrawal1, Fadi Nabhan1

Abstract:

Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves' disease, however, has been rarely reported with this medication. Here we report a case of Graves' disease diagnosed after initiation of ipilimumab in a patient with melanoma. Methods. We present the ... Objective. Thyroid disease has been reported among the endocrinopathies that can occur after treatment with ipilimumab. Graves' disease, however, has been rarely reported with this medication. Here we report a case of Graves' disease diagnosed after initiation of ipilimumab in a patient with melanoma. Methods. We present the clinical presentation and management course of this patient followed by a related literature review. Results. A 67-year-old male with metastatic melanoma was started on ipilimumab. He developed hyperthyroidism after two doses of ipilimumab. The cause of hyperthyroidism was determined to be Graves' disease. Ipilimumab was held and the patient was started on methimazole with return to euthyroid status. Ipilimumab was resumed and the patient continued methimazole during the course of ipilimumab therapy, with controlled hyperthyroidism. Restaging studies following four cycles of ipilimumab showed complete response in the lungs, with residual melanoma in the neck. The patient then underwent total thyroidectomy and left neck dissection as a definitive treatment for both hyperthyroidism and residual melanoma. Conclusion. Graves' disease can develop after starting ipilimumab and methimazole can be an effective treatment. For patients whose hyperthyroidism is well-controlled on methimazole, ipilimumab may be resumed with close monitoring. read more read less

Topics:

Ipilimumab (62%)62% related to the paper, Graves' disease (56%)56% related to the paper, Thyroid disease (51%)51% related to the paper
View PDF
45 Citations
open accessOpen access Journal Article DOI: 10.1155/2012/165056
Reversal of the Symptoms of Diabetic Neuropathy through Correction of Vitamin D Deficiency in a Type 1 Diabetic Patient
David S.H. Bell1

Abstract:

Vitamin D deficiency has been associated with both type 1 and type 2 diabetes as well as both the microvascular and macrovascular complications of diabetes. Vitamin D deficiency has been shown to be more common in diabetic patients who have symptoms of distal symmetrical polyneuropathy. In addition, vitamin D deficiency has b... Vitamin D deficiency has been associated with both type 1 and type 2 diabetes as well as both the microvascular and macrovascular complications of diabetes. Vitamin D deficiency has been shown to be more common in diabetic patients who have symptoms of distal symmetrical polyneuropathy. In addition, vitamin D deficiency has been associated with a lower pain threshold which increases when vitamin D deficiency is corrected. Herein, I describe a type 1 diabetic patient with neuropathic symptoms so severe that he could not work and for which he needed narcotics for pain management and whose symptoms improved dramatically with correction of the vitamin D deficiency. To my knowledge, this is the first report of an improvement in severe symptoms of diabetic neuropathy with correction of vitamin D deficiency in a single patient. read more read less

Topics:

vitamin D deficiency (66%)66% related to the paper, Diabetic neuropathy (57%)57% related to the paper, Polyneuropathy (54%)54% related to the paper, Diabetes mellitus (53%)53% related to the paper, Type 2 diabetes (53%)53% related to the paper
View PDF
40 Citations
open accessOpen access Journal Article DOI: 10.1155/2014/807054
Unpredictable nature of tolvaptan in treatment of hypervolemic hyponatremia: case review on role of vaptans.

Abstract:

Hyponatremia is one of the most commonly encountered electrolyte abnormalities occurring in up to 22% of hospitalized patients. Hyponatremia usually reflects excess water retention relative to sodium rather than sodium deficiency. Volume status and serum osmolality are essential to determine etiology. Treatment depends on sev... Hyponatremia is one of the most commonly encountered electrolyte abnormalities occurring in up to 22% of hospitalized patients. Hyponatremia usually reflects excess water retention relative to sodium rather than sodium deficiency. Volume status and serum osmolality are essential to determine etiology. Treatment depends on several factors, including the cause, overall volume status of the patient, severity of hyponatremic symptoms, and duration of hyponatremia at presentation. Vasopressin antagonists like tolvaptan seem promising for the treatment of euvolemic and hypervolemic hyponatremia in heart failure. Low sodium concentrations cause cerebral edema, but the overly rapid sodium correction can also lead to iatrogenic cerebral osmotic demyelination syndrome. Demyelination may occur days after sodium correction or initial neurologic recovery from hyponatremia. The following case report analyzes the role of vasopressin antagonists in the treatment of hyponatremia and the need for daily dosing of tolvaptan and the monitoring of serum sodium levels to avoid rapid overcorrection which can result in osmotic demyelination syndrome (ODS). read more read less

Topics:

Hyponatremia (66%)66% related to the paper, Tolvaptan (64%)64% related to the paper, Vasopressin Antagonists (63%)63% related to the paper, Low sodium (60%)60% related to the paper
View PDF
35 Citations
open accessOpen access Journal Article DOI: 10.1155/2015/510985
Early Onset Primary Hyperparathyroidism Associated with a Novel Germline Mutation in CDKN1B

Abstract:

Individuals presenting with primary hyperparathyroidism (PHPT) at a young age commonly have an underlying germline gene mutation in one of the following genes: MEN1, CASR, or CDC73. A small number of families with primary hyperparathyroidism have been identified with germline mutations in CDKN1B and those patients with primar... Individuals presenting with primary hyperparathyroidism (PHPT) at a young age commonly have an underlying germline gene mutation in one of the following genes: MEN1, CASR, or CDC73. A small number of families with primary hyperparathyroidism have been identified with germline mutations in CDKN1B and those patients with primary hyperparathyroidism have almost exclusively been women who present in middle age suggesting that the age of onset of PHPT in MEN4 may be later than that of MEN1. We present a case of apparently sporadic PHPT presenting in adolescence with single gland disease associated with a novel CDKN1B germline mutation (heterozygote for a missense mutation in exon 1 of the CDKN1B gene (c.378G>C) (p.E126D)). The implication from this case is that CDKN1B germline mutations may be associated with PHPT at an earlier age than previously thought. read more read less

Topics:

Germline mutation (64%)64% related to the paper, Gene mutation (58%)58% related to the paper, Primary hyperparathyroidism (54%)54% related to the paper, Missense mutation (54%)54% related to the paper, Germline (53%)53% related to the paper
View PDF
29 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Case Reports in Endocrinology.

It automatically formats your research paper to Hindawi formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Case Reports in Endocrinology format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Case Reports in Endocrinology in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Case Reports in Endocrinology guidelines and auto format it.

2. Do you follow the Case Reports in Endocrinology guidelines?

Yes, the template is compliant with the Case Reports in Endocrinology guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Case Reports in Endocrinology?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Case Reports in Endocrinology citation style.

4. Can I use the Case Reports in Endocrinology templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Case Reports in Endocrinology.

5. Can I use a manuscript in Case Reports in Endocrinology that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Case Reports in Endocrinology that you can download at the end.

6. How long does it usually take you to format my papers in Case Reports in Endocrinology?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Case Reports in Endocrinology.

7. Where can I find the template for the Case Reports in Endocrinology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Case Reports in Endocrinology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Case Reports in Endocrinology's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Case Reports in Endocrinology an online tool or is there a desktop version?

SciSpace's Case Reports in Endocrinology is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Case Reports in Endocrinology?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Case Reports in Endocrinology?”

11. What is the output that I would get after using Case Reports in Endocrinology?

After writing your paper autoformatting in Case Reports in Endocrinology, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Case Reports in Endocrinology's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Case Reports in Endocrinology?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Case Reports in Endocrinology. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Case Reports in Endocrinology?

The 5 most common citation types in order of usage for Case Reports in Endocrinology are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Case Reports in Endocrinology?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Case Reports in Endocrinology's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Case Reports in Endocrinology in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Case Reports in Endocrinology Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Case Reports in Endocrinology formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template